The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis
Open accessAbstract
Isoniazid (INH) is a central component of drug regimens used worldwide to treat tuberculosis. Previous studies have identified resistance-associated mutations in katG , inhA , kasA , ndh , and the oxyR-ahpC intergenic region. DNA microarray-based experiments have shown that INH induces several genes in Mycobacterium tuberculosis that encode proteins physiologically relevant to the drug's mode of action. To gain further insight into the molecular genetic basis of INH resistance, 20 genes implicated in INH resistance were sequenced for INH resistance-associated mutations. Thirty-eight INH-monoresistant clinical isolates and 86 INH-susceptible isolates of M. tuberculosis were obtained from the Texas Department of Health and the Houston Tuberculosis Initiative. Epidemiologic independence was established for all isolates by IS 6110 restriction fragment length polymorphism analysis. Susceptible isolates were matched with resistant isolates by molecular genetic group and IS 6110 profiles. Spoligotyping was done with isolates with five or fewer IS 6110 copies. A major genetic group was established on the basis of the polymorphisms in katG codon 463 and gyrA codon 95. MICs were determined by the E-test. Semiquantitative catalase assays were performed with isolates with mutations in the katG gene. When the 20 genes were sequenced, it was found that 17 (44.7%) INH-resistant isolates had a single-locus, resistance-associated mutation in the katG , mabA , or Rv1772 gene. Seventeen (44.7%) INH-resistant isolates had resistance-associated mutations in two or more genes, and 76% of all INH-resistant isolates had a mutation in the katG gene. Mutations were also identified in the fadE24 , Rv1592c , Rv1772 , Rv0340 , and iniBAC genes, recently shown by DNA-based microarray experiments to be upregulated in response to INH. In general, the MICs were higher for isolates with mutations in katG and the isolates had reduced catalase activities. The results show that a variety of single nucleotide polymorphisms in multiple genes are found exclusively in INH-resistant clinical isolates. These genes either are involved in mycolic acid biosynthesis or are overexpressed as a response to the buildup or cellular toxicity of INH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 5×
“The Rv0340 gene is located upstream of the iniBAC operon and is transcribed in the same orientation (10).”
Influentialvan Embden, J. D., Cave, M. D., Crawford, J. T., Dale, J. W., Eisenach, K. D., Gicquel, B., Hermans, P., Martin, C., McAdam, R., & Shinnick, T. M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.406-409.1993 · Cited by 2,342
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 2×
“Also, the mutations identified in the structural part of inhA results in INH resistance due to a reduced binding affinity of the INHNAD adduct for enoyl reductase (4, 7, 29).”
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Self-citationSreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationWilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Self-citationGlobal Tuberculosis Programme, & Disease, L. (1997) · Medical Entomology and Zoology · Cited by 361
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Pym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Brennan, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000569200 · Cited by 256
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
Self-citationIsoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Slayden, R. A., Lee, R. E., Jr., & Barry, C. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02145.x · Cited by 172
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 163
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
BERNSTEIN, J., Lott, W. A., Steinberg, B. A., & Yale, H. L. (1952) · PubMed · doi:10.1164/art.1952.65.4.357 · Cited by 160
Trends in Drug-Resistant Tuberculosis in the United States, 1993-1996
Moore, M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550100059039 · Cited by 159
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Self-citationahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex
Wilson, T. M., & Collins, D. M. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.449980.x · Cited by 148
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 145
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG
Zahrt, T. C., Song, J., Siple, J., & Deretic, V. P. (2001) · Molecular Microbiology · doi:10.1111/j.1365-2958.2001.02321.x · Cited by 140
Pym, A. S., Domenech, P., Honoré, N., Song, J., Deretic, V., & Cole, S. T. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02427.x · Cited by 138
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Kelley, C. L., Rouse, D. A., & Morris, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2057 · Cited by 110
Mechanism of isoniazid uptake in Mycobacterium tuberculosis
Bardou, F., Raynaud, C., Ramos, C., et al. (1998) · Microbiology · doi:10.1099/00221287-144-9-2539 · Cited by 109
Banerjee, A., Sugantino, M., Sacchettini, J. C., & Jacobs, W. R. (1998) · Microbiology · doi:10.1099/00221287-144-10-2697 · Cited by 96
Geistlich, M., Losick, R. M., Turner, J. R., & Rao, R. N. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01374.x · Cited by 89
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 86
Chemotherapy of Experimental Tuberculosis.
Perlman, H., BROWN, H., & Raiziss, G. W. (1941) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 86
Wanger, A. R., & Mills, K. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.7.1672-1676.1996 · Cited by 74
Self-citationIsoniazid-Resistance and Catalase Activity of Tubercle Bacilli1
Middlebrook, G. (2019) · American Review of Tuberculosis · Cited by 70
Abate, G., Hoffner, S., Thomsen, V. Ø., & Miörner, H. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011272 · Cited by 59
van Doorn, H. R., Kuijper, E. J., ENDE, A. V. D., Welten, A. G. A., van Soolingen, D., de Haas, P. E. W., & Dankert, J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1591-1594.2001 · Cited by 56
Cited by
Mycobacterium abscessus: a new antibiotic nightmare
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr578 · Cited by 799
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Palomino, J., & Martin, A. (2014) · Antibiotics · doi:10.3390/antibiotics3030317 · Cited by 442
Zhang, H., Li, D., Zhao, L., Fleming, J., Lin, N., Wang, T., Liu, Z., Li, C., Galwey, N., Deng, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2735 · Cited by 429
Metadata
- Authors
- Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-04
- Volume
- 47
- Issue
- 4
- Pages
- 1241-1250
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2113280970
- Cited by
- 336
- References
- 44
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.